SMTI vs. CL
SMTI (Sanara MedTech Inc.) and CL (Colgate-Palmolive Company) are both stocks. SMTI operates in Medical Instruments & Supplies (Healthcare), while CL operates in Household & Personal Products (Consumer Defensive). Over the past 10 years, SMTI returned 18.89%/yr vs 4.44%/yr for CL. Their 0.05 correlation means their historical movements had little consistent relationship.
Performance
SMTI vs. CL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SMTI achieves a 45.01% return, which is significantly higher than CL's 17.64% return. Over the past 10 years, SMTI has outperformed CL with an annualized return of 18.89%, while CL has yielded a comparatively lower 4.44% annualized return.
SMTI
- 1D
- -0.59%
- 1M
- 36.31%
- 6M
- 53.91%
- YTD
- 45.01%
- 1Y
- 40.15%
- 3Y*
- -6.97%
- 5Y*
- -3.80%
- 10Y*
- 18.89%
- ALL TIME*
- -2.74%
CL
- 1D
- -0.33%
- 1M
- -3.48%
- 6M
- 2.33%
- YTD
- 17.64%
- 1Y
- 12.06%
- 3Y*
- 8.52%
- 5Y*
- 5.29%
- 10Y*
- 4.44%
- ALL TIME*
- 10.28%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $438.38M | $416.63M | $459.32M | |
| $15.54M | $8.15M | $3.59M |
SMTI vs. CL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SMTI Sanara MedTech Inc. | 45.01% | -29.67% | -19.22% | -9.67% | 53.98% | -40.78% | 209.94% | 393.11% | -45.58% | 58.31% |
CL Colgate-Palmolive Company | 17.64% | -10.98% | 16.57% | 3.78% | -5.44% | 2.08% | 27.17% | 18.60% | -19.19% | 17.88% |
Correlation
The correlation between SMTI and CL is 0.17, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.17 |
Correlation (3Y) Balances recent behavior with more history. | 0.11 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.10 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.06 |
Correlation (All Time) Calculated using the full available price history since Feb 22, 2011 | 0.05 |
The correlation between SMTI and CL shifts across timeframes, from 0.05 (all time) to 0.17 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
SMTI:
$310.29M
CL:
$73.06B
SMTI:
-$3.79
CL:
$2.53
SMTI:
2.79
CL:
3.50
SMTI:
43.29
CL:
311.74
SMTI:
$107.48M
CL:
$21.05B
SMTI:
$97.21M
CL:
$12.72B
SMTI:
$16.13M
CL:
$3.68B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SMTI vs. CL — Risk / Return Rank
SMTI
CL
SMTI vs. CL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Sanara MedTech Inc. (SMTI) and Colgate-Palmolive Company (CL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SMTI | CL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.10 | ||
| Sortino ratioReturn per unit of downside risk | +0.40 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 1.10 | +0.06 |
| Calmar ratioReturn relative to maximum drawdown | 0.74 | 0.69 | +0.05 |
| Martin ratioReturn relative to average drawdown | 1.16 | 1.37 | -0.21 |
Loading charts...
Drawdowns
SMTI vs. CL - Drawdown Comparison
The maximum SMTI drawdown since its inception was -97.48%, which is greater than CL's maximum drawdown of -58.91%. Use the drawdown chart below to compare losses from any high point for SMTI and CL.
Loading charts...
Drawdown Indicators
| SMTI | CL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.48% | -58.91% | -38.57% |
Max Drawdown (1Y)Largest decline over 1 year | -54.29% | -16.97% | -37.32% |
Max Drawdown (3Y)Largest decline over 3 years | -64.47% | -29.05% | -35.42% |
Max Drawdown (5Y)Largest decline over 5 years | -67.11% | -29.05% | -38.06% |
Max Drawdown (10Y)Largest decline over 10 years | -81.82% | -29.05% | -52.77% |
Current DrawdownCurrent decline from peak | -57.41% | -12.03% | -45.38% |
Average DrawdownAverage peak-to-trough decline | -75.16% | -11.24% | -63.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 34.54% | 8.47% | +26.07% |
Volatility
SMTI vs. CL - Volatility Comparison
Sanara MedTech Inc. (SMTI) has a higher volatility of 19.72% compared to Colgate-Palmolive Company (CL) at 7.62%. This indicates that SMTI's price experiences larger fluctuations and is considered to be riskier than CL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SMTI | CL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.72% | 7.62% | +12.10% |
Volatility (6M)Calculated over the trailing 6-month period | 43.20% | 17.78% | +25.42% |
Volatility (1Y)Calculated over the trailing 1-year period | 65.06% | 22.53% | +42.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 56.67% | 18.97% | +37.70% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 108.92% | 19.87% | +89.05% |
Dividends
SMTI vs. CL - Dividend Comparison
SMTI has not paid dividends to shareholders, while CL's dividend yield for the trailing twelve months is around 2.30%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CL Colgate-Palmolive Company | 2.30% | 2.61% | 2.18% | 2.40% | 2.36% | 2.10% | 2.05% | 2.48% | 2.79% | 2.11% | 2.37% | 2.25% |
SMTI Sanara MedTech Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
SMTI vs. CL - Financials Comparison
This section allows you to compare key financial metrics between Sanara MedTech Inc. and Colgate-Palmolive Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SMTI vs. CL - Profitability Comparison
SMTI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Sanara MedTech Inc. reported a gross profit of 25.87M and revenue of 27.80M. Therefore, the gross margin over that period was 93.1%.
CL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Colgate-Palmolive Company reported a gross profit of 3.30B and revenue of 5.36B. Therefore, the gross margin over that period was 61.5%.
SMTI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Sanara MedTech Inc. reported an operating income of 2.65M and revenue of 27.80M, resulting in an operating margin of 9.5%.
CL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Colgate-Palmolive Company reported an operating income of 1.02B and revenue of 5.36B, resulting in an operating margin of 19.0%.
SMTI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Sanara MedTech Inc. reported a net income of 458.96K and revenue of 27.80M, resulting in a net margin of 1.7%.
CL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Colgate-Palmolive Company reported a net income of 693.00M and revenue of 5.36B, resulting in a net margin of 12.9%.
Frequently Asked Questions
SMTI and CL have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SMTI has higher volatility (19.72%) compared to CL (7.62%). In terms of maximum drawdown, SMTI dropped -97.48% vs CL's -58.91%.
SMTI currently has the higher Sharpe Ratio (0.62 vs 0.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SMTI and CL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer